A novel mechanism that enables cells to maintain energy production even when their main power supply drops/fails has been ...

Heart disease remains the top global killer. Learn about its impact on health, key risk factors, and approaches to prevention ...

A study by Emory cardiovascular researchers has paved the way for the development of a new cardiovascular reactivity risk ...

Heart disease remains the number one killer worldwide, outstripping all other causes of death as key risk factors continue to ...

(Reuters) -The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, ...

Cardiovascular disease remains a leading cause of death in the U.S., with high blood pressure, obesity, and diabetes ...

Heart disease and stroke claim more lives in the United States than all forms of cancer and accidental deaths combined, according to a new American Heart Association report.

The AHA's 2025 report highlights alarming trends in cardiovascular disease, obesity, and lifestyle factors, emphasizing the ...

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure.

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

While the project only used mice as its subjects, scientists believe that similar damage could effect 'many years in a human lifespan' ...